Mostrando 5 resultados de: 5
Filtros aplicados
Publisher
Advances in Alzheimer's Disease(1)
Brain Research(1)
Journal of Alzheimer's Disease(1)
Nutrition Research(1)
The Lancet Neurology(1)
Área temáticas
Fisiología humana(5)
Farmacología y terapéutica(2)
Fisiología y materias afines(1)
Ginecología, obstetricia, pediatría, geriatría(1)
Origen
scopus(5)
Neuroprotective effects of the amylin analog, pramlintide, on Alzheimer's disease are associated with oxidative stress regulation mechanisms
ArticleAbstract: Administration of the recombinant analog of the pancreatic amyloid amylin, Pramlintide, has shown thPalabras claves:Alzheimer's disease, amylin, metabolism, neuroprotection, Oxidative Stress, pramlintideAutores:Antoni Camins, Blair J., Casadesús G., Corrigan R., Grizzanti J., Lee H.g., Mey M., Pallás M., Patrick S.Fuentes:scopusUnveiling "the switch" from aging to Alzheimer's disease with the senescence-accelerated mouse model (SAMP8)
ReviewAbstract: Current mouse models of Alzheimer's disease (AD) are restricted to the expression of AD-related pathPalabras claves:aging, Alzheimer's disease, Amyloid-β, Animal models, COGNITION, Gliosis, Neurodegeneration, Oxidative Stress, SAMP8, Tau phosphorylationAutores:Antoni Camins, Casadesús G., Chang J., Kim H.J., Lee H.g., Pallás M., Perry G., Smith M.A., Zhu X.Fuentes:scopusThe effect of mGluR2 activation on signal transduction pathways and neuronal cell survival
ArticleAbstract: In earlier studies, we found profound alterations in specific signal transduction pathways such as mPalabras claves:ERK, mGluR2, neuroprotectionAutores:Antoni Camins, Casadesús G., Lee H.g., Nakanishi S., O'Neill M.J., Pallás M., Perry G., Smith M.A., Zhu X.Fuentes:scopusThe sirtuin pathway in ageing and Alzheimer disease: Mechanistic and therapeutic considerations
OtherAbstract: Background: Advances in gerontology have yielded crucial insights into the molecular and biochemicalPalabras claves:Autores:Antoni Camins, Bonda D.J., Casadesús G., Lee H.g., Pallás M., Smith M.A., Zhu X.Fuentes:scopusThe therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease
ReviewAbstract: Aging leads to a number of physiological alterations, specifically changes in circulating hormone lePalabras claves:Alzheimer disease, amylin, DIABÉTES, Insulin, leptin, obesityAutores:Antoni Camins, Casadesús G., Grizzanti J., Lee H.g., Pallás M.Fuentes:scopus